The MVP Act is expected to have significant implications for healthcare delivery and drug pricing under Medicaid, particularly in enhancing patient access to innovative treatments, such as gene therapies for rare diseases. The bill mandates that state Medicaid programs must utilize a pricing structure that reflects these value-based purchases, thereby aiming to improve health outcomes while potentially lowering costs for patients and the overall healthcare system. Furthermore, it necessitates state Medicaid agency guidance on entering agreements for value-based purchasing arrangements to facilitate cooperation among states and manufacturers.
Summary
House Bill 7871, also known as the MVP Act (Medicaid VBPs for Patients Act), aims to amend title XIX of the Social Security Act to codify value-based purchasing arrangements within the Medicaid program. The bill specifically addresses reforms related to price reporting for these arrangements and aims to improve the pricing structure for outpatient drugs provided under Medicaid. The proposed changes will ensure that state Medicaid programs can access value-based purchasing arrangements that are comparable to those available in the commercial market, ultimately enhancing patient access to necessary medications.
Contention
Despite its potential benefits, the MVP Act may encounter contention, particularly regarding the details and execution of value-based purchasing arrangements. Concerns may arise around the complexities of price reporting and enforcement, as well as the effectiveness of these arrangements in genuinely improving patient outcomes. Critics may argue about ensuring equitable access to all patients and preventing socioeconomic disparities that could arise if such purchasing methods are not carefully implemented. The legislation also proposes a study by the Comptroller General to evaluate how well these arrangements work in practice, which may lead to further scrutiny and debate about their long-term viability and impact.
Kids' Access to Primary Care Act of 2025This bill modifies payments for Medicaid primary care services. Specifically, the bill applies a Medicare payment rate floor to Medicaid primary care services that are provided after the date of enactment of the bill and extends the payment rate to additional types of practitioners (e.g., obstetricians).The Centers for Medicare & Medicaid Services must conduct a study on the number of children enrolled in Medicaid, the number of providers receiving payment for primary care services, and associated payment rates before and after the bill's implementation.